Better Vaccines and Therapeutics At Your Doorstep

Vaxess’s MIMIX™ platform combines multiple breakthrough technologies to enable better vaccines and complex biologics that are easily delivered at home.

 

Introducing the MIMIX™ Platform

The MIMIX™ platform is transforming medicinal delivery. Once placed on the skin, each MIMIX™ transdermal patch delivers bioactive tips into the immunologically active dermal barrier. These bioactive tips gradually dissolve into the body after the patch is removed, releasing their payload of vaccines and therapeutics over time.

 
 
Vaxess-Mimix-logo-white-wide.png
 
 

Facilitating simple, pain-free, broadly distributed delivery of vaccines and other biologics.

The MIMIX™ platform is designed to be needle-free, virtually painless, and easy-to-use. It is also engineered to be consistent and flexible across a wide range of payloads.

The slow-release, bioactive tips that make this possible are made from silk fibroin proteins—unlike any other existing technology.

Seeking to dismantle barriers to vaccination and therapeutics use, Vaxess work to overcome the limitations of conventional needle administration and to create a vastly improved user experience. That's why Vaxess designed the MIMIX™ platform to be needle-free, virtually pain-free, and easy-to-use, resembling an adhesive bandage. The patch is applied with a preloaded applicator and removed after a few minutes; no sharps bin required.

The MIMIX™ platform is shelf stable, so it can be shipped via simplified, lower-cost supply chains, and applied anywhere, including your doorstep or low-resource settings.

 
 
 

 MIMIX™ Microarray in Action

Once placed on the skin, each MIMIX™ transdermal patch delivers a microarray of slow-release, bioactive tips into the body's most effective immunological organ: the dermal barrier. These bioactive tips gradually dissolve into the body after the patch is removed.

 

Easy and Accessible

MIMIX is designed for efficient, remote delivery and simple, short wear time. At home, in the field, or into extreme environments - MIMIX goes where traditional vaccines and therapeutics can't.

 

Flexible and Consistent

The MIMIX™ platform offers many advantages when it comes to drug delivery, but its biggest strengths and primary points of differentiation are consistency and flexibility.

 
VAXESS-icon-distribution.png

Optimized Distribution

Favorable shelf-stability eliminates cold chain requirements to drive availability of vaccines and therapeutics to people and communities in the U.S. and around the world.

Engineered for Adaptability

Our in-house manufacturing line is built to accommodate variable array sizes, enabling the platform to deliver a wide range of payloads and doses.

VAXESS-icon-patient-10.png

Improved experience for people

Pain-free, needle-free and easy-to-use, MIMIX™ can be administered right in the comfort of your own home.

Consistent Delivery

Dissolving tips allow the MIMIX™ platform to deliver doses more consistently than competition.

 

VERSATILE PLATFORM

A Versatile Platform

Vaxess has generated strong clinical and in-vivo proof of concept in the MIMIX™ platform with a range of molecules, demonstrating flexibility.